Zimbabwe

Zimbabwe country outline

Estimated Number of Current PrEP Users

3,500-4,000

Aggregate Target Number of PrEP Users from All Projects (Planned and Ongoing)

3,000-3,500

PEPFAR Target in COP 2017

2,769

Types of Delivery Projects

  • Open-label extension
  • Implementation project
  • Clinical trials
  • Large-scale implementation initiative
  • Product introduction and support project

*Definitions of types of projects available in the glossary below.

Drug Registration Status

  • Gilead’s Truvada (TDF/FTC) is registered and approved for prevention
  • Generic versions of TDF/FTC registered for prevention

Research, Demonstration and Implementation Projects

Click here for a full list of ongoing and planned projects in Zimbabwe

Policy Framework

  • Implementation Plan for HIV Pre-Exposure Prophylaxis in Zimbabwe 2018-2020
  • Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe 2013
  • Funding

    NIAID, NIMH, NICHD, USAID, The Bill & Melinda Gates Foundation, PEPFAR, NIH, DAIDS, DFID, UNFPA, IMPAACT Network, MTN, IPM, Nike Foundation

    Selected Technical & Strategic Assistance


    Eligibility Criteria
    Resources for Zimbabwe
    Glossary of Terms

    Last updated September 30, 2018.

News Spotlight